ROSTROPOVICH-VISHNEVSKAYA FOUNDATION
1776 K STREET NW 7TH FLOOR, WASHINGTON, DC 20006 www.rostropovich.org

---

Organizations Filed Purposes: THE ROSTROPOVICH-VISHNEVSKAYA FOUNDATION (RVF) IS A GLOBAL DEVELOPMENT ORGANIZATION THAT PROMOTES THE HEALTH AND WELLBEING OF CHILDREN IN NEED THROUGH PARTNERSHIPS THAT CREATE SUSTAINABLE, TRANSFORMATIONAL PUBLIC HEALTH PROGRAMS AROUND THE WORLD. RVF IS A NON-POLITICAL, NON-PARTISAN CHARITABLE ORGANIZATION.

RVF DESIGNS AND FINANCES NATIONWIDE SUSTAINABLE HEALTHCARE INITIATIVES BENEFITING PREGNANT WOMEN AND CHILDREN.

RVF WORKS IN PARTNERSHIP WITH LOCAL GOVERNMENTS TO CREATE SUSTAINABLE PUBLIC HEALTH PROGRAMS FOR CHILDREN. THE LARGEST SERVICE ACCOMPLISHMENTS ARE PROGRAMS INTRODUCING MODERN VACCINES FOR CHILDREN INTO THE NATIONAL ROUTINE VACCINATION SCHEDULES IN MIDDLE INCOME COUNTRIES (MICS) AND PUBLISHING THE EPIDEMIOLOGICAL RESULTS OF THE PROGRAMS IN PEER-REVIEWED SCIENTIFIC JOURNALS. THE PROGRAMS ARE IMPLEMENTED ENTIRELY BY LOCAL HEALTH CARE WORKERS, THEREBY BUILDING LOCAL CAPACITY AND OWNERSHIP FROM THE BEGINNING, AND ARE FULLY SUSTAINED BY THE HOST GOVERNMENTS WITHIN 3 YEARS OF INCEPTION. THANKS TO RVF-SUPPORTED VACCINATION PROGRAMS OVER 10 MILLION YOUNG CHILDREN, STUDENTS AND MEDICAL WORKERS IN SUCH DIVERSE GEOGRAPHIC LOCATIONS AS THE CAUCASUS, RUSSIA, THE WEST BANK AND GAZA HAVE BEEN VACCINATED AGAINST KILLER DISEASES SUCH AS PNEUMONIA, MENINGITIS, MEASLES, HEPATITIS B, AND ROTAVIRUS. EACH OF THESE COMPLETED VACCINATION PROGRAMS IS NOW BEING FULLY SUSTAINED WITH LOCAL RESOURCES. IN 2020, THE RVF INITATIATED ROTAVIRUS VACCINATION PROGRAM FOR ALL INFANTS IN GAZA AND THE WEST BANK - APPROXIMATELY 135,000 BABIES ANNUALLY - CONTINUED TO BE FULLY SUSTAINED BY THE PALESTINIAN MINISTRY OF HEALTH, WHICH CLEARLY DEMONSTRATES THAT THE RVF MODEL OF CREATING SUSTAINABLE CHILDREN'S HEALTH PROGRAMS WORKS EVEN IN POLITICALLY AND ECONOMICALLY CHALLENGING SETTINGS DURING A PANDEMIC! VACCINATION COVERAGE RATES ARE >97%, AND HEALTH FACILITIES ACROSS THE WEST BANK AND GAZA HAVE SEEN A SIGNIFICANT DROP IN CHILDREN PRESENTING WITH ACUTE WATERY DIARRHEA SINCE THE INTRODUCTION OF THE ROTAVIRUS VACCINE. IN PARTNERSHIP WITH PATH AND WITH FINANCING FROM THE BMGF RVF NEARED COMPLETION OF ROTAVIRUS SURVEILLANCE DOCUMENTING THE IMPACT OF THE ROTAVIRUS VACCINE ON THE DISEASE BURDEN, WHICH WILL BE WRITTEN UP FOR PUBLICATION IN A PEER-REVIEWED JOURNAL. RVF ASSISTED THE PALESTINIAN MOH TO SWITCH TO A NEW PNEUMOCOCCAL CONJUGATE VACCINE (PCV), WHICH WILL RESULT IN SIGNIFICANT SAVINGS TO THE MOH. DESPITE MAJOR CHALLENGES CAUSED BY THE CORONAVIRUS PANDEMIC, RVF WAS ABLE TO LAUNCH THE SECOND 3-YEAR RESEARCH ON PNEUMOCOCCAL DISEASE FINANCED BY PFIZER IN RUSSIA AND KAZAKHSTAN, AND ADDED TWO OTHER COUNTRIES, UZBEKISTAN AND BELARUS, TO THE RESEARCH. THE PROGRAM HAS AN IMPORTANT LABORATORY CAPACITY BUILDING COMPONENT IN EACH OF THE THREE COUNTRIES. THE INITIAL EPIDEMIOLOGICAL FINDINGS WERE PUBLISHED IN AN IMPORTANT PEER-REVIEWED JOURNAL, DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE. IN NOVEMBER 2020 RVF BEGAN ITS ROTAVIRUS SURVEILLANCE IN EGYPT FINANCED BY THE BMGF. THIS REPRESENTS THE FIRST PHASE OF A COMPREHENSIVE ROTAVIRUS INITIATIVE IN THE COUNTRY, WHICH INCLUDES THE NATIONWIDE INTRODUCTION OF THE ROTAVIRUS VACCINE FOR INFANTS AND THE TRANSFER OF THE VACCINE MANUFACTURING TECHNOLOGY TO EGYPT.

---

---

Data for this page was sourced from XML published by IRS (public 990 form dataset) from: https://s3.amazonaws.com/irs-form-990/202101039349301345_public.xml